Advisory Board December 9, 2025
Since injectable GLP-1 drugs were approved, they have exploded in popularity, with millions of patients currently taking them. Now, drugmakers have formulated new GLP-1 pills, which are cheaper to manufacture and easier to take — potentially increasing access to the medication.
New weight-loss pills could soon be approved
According to a recent KFF poll, one in eight people are currently taking an injectable GLP-1 drug. Although these drugs are effective, they require weekly injections and can be expensive, especially without insurance.
However, patients could soon access new, cheaper versions of these drugs. Currently, both Novo Nordisk, which manufactures Ozempic and Wegovy, and Eli Lilly, which manufactures Mounjaro and Zepbound, are preparing new, daily GLP-1 pills for FDA approval.
Novo’s new...
Today's Sponsors
Today's Sponsor